Menu Close

Articles on Vaccine development

Displaying 1 - 20 of 64 articles

Inhaled vaccine delivery could take on not only COVID-19, but also other respiratory infections, including tuberculosis. (Shutterstock)

Inhaled vaccine for COVID-19: The pandemic accelerated decades of research leading to jab-free vaccine now in human testing

An inhaled COVID-19 vaccine would go directly to where the body would use it: the mucosal surface of the airways. This could mean less waste and more benefit, lower costs and reduced side-effects.
On Dec. 8, 2020, the first members of the public were given doses of a coronavirus vaccine. AP Photo/Frank Augstein, Pool

International Statistic of the Year: Race for a COVID-19 vaccine

The coronavirus vaccine was developed faster than any vaccine in history. It took just 332 days from the first sequencing of the virus genome to the first vaccines given to the public.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Mink can be readily infected with SARS-CoV-2 and then pass the virus to humans. (Shutterstock)

The mink link: How COVID-19 mutations in animals affect human health and vaccine effectiveness

In the disturbing scenario of human-to-mink-to-human COVID-19 transmission, the virus may mutate in mink prior to re-infecting people. That possibility makes vaccine design even more crucial.
Samples from volunteers are handled in the laboratory at Imperial College in London, on July 30, 2020. Imperial College is working on the development of a COVID-19 vaccine. (AP Photo/Kirsty Wigglesworth)

Canada’s COVID-19 Vaccine Task Force needs better transparency about potential conflicts of interest

With lives depending on a vaccine, trust in Canada’s COVID-19 Vaccine Task Force is crucial. Members of the task force need to make any industry links or potential conflicts of interest publicly clear.

Top contributors

More